Kannel WB, Wolf PA, Verter J, et al. Epidemiologic assessment of the role of blood pressure in stroke. The framingham study[J]. JAMA, 1970, 214:301-310.

 Norris JW, Hachinski VC. Intensive care management of stroke patients[J]. Stroke, 1976, 7:573-577.

The canadian cooperative study group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke[J]. N Engl J Med, 1978, 299:53-59.

 The national institute of neurological disorders and stroke rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke[J]. N Engl J Med, 1995, 333:1581-1587.

 Gahremanpour A, Perin EC, Silva G. Carotid artery stenting versus endarterectomy:A systematic review[J]. Tex Heart Inst J, 2012, 39:474-487.

 Hachinski V, Donnan GA, Gorelick PB, et al. Stroke:Working toward a prioritized world agenda[J]. Int J Stroke, 2010, 5:238-256.

 Staessen JA, Jiguang W. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack[J]. Lancet, 2001, 358:1033-1041.

 Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics-2007 update:A report from the american heart association statistics committee and stroke statistics subcommittee[J]. Circulation, 2007, 115:e69-171.

Amarenco P, Bogousslavsky J, Callahan A 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack[J]. N Engl J Med, 2006, 355:549-559.

 Biffi A, Devan WJ, Anderson CD, et al. Statin treatment and functional outcome after ischemic stroke:Case-control and meta-analysis[J]. Stroke, 2011, 42:1314-1319.

 Goldstein LB, Amarenco P, Szarek M, et al. Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study[J]. Neurology, 2008, 70:2364-2370.

 Romano JG, Sacco RL. Progress in secondary stroke prevention[J]. Ann Neurol, 2008, 63:418-427.

 Vaughan CJ, Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke[J]. Stroke, 1999, 30:1969-1973.

 Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack:A statement for healthcare professionals from the american heart association/american stroke association council on stroke:Co-sponsored by the council on cardiovascular radiology and intervention:The american academy of neurology affirms the value of this guideline[J]. Circulation, 2006, 113:e409-449.

 Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update:A report from the american heart association[J]. Circulation, 2010, 121:e46-e215.

 Rothwell PM, Warlow CP. Timing of tias preceding stroke:Time window for prevention is very short[J]. Neurology, 2005, 64:817-820.

 Hackam DG, Kapral MK, Wang JT, et al. Most stroke patients do not get a warning:A population-based cohort study[J]. Neurology, 2009, 73:1074-1076.

 Kennedy J, Hill MD, Ryckborst KJ, et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence(faster):A randomised controlled pilot trial[J]. Lancet Neurol, 2007, 6:961-969.

 Leary MC, Saver JL. Annual incidence of first silent stroke in the united states:A preliminary estimate[J]. Cerebrovasc Dis, 2003, 16:280-285.

 Strong K, Mathers C, Bonita R. Preventing stroke:Saving lives around the world[J]. Lancet Neurol, 2007, 6:182-187.

 Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update:A report from the american heart association[J]. Circulation, 2011, 123:e18-e209.